187 related articles for article (PubMed ID: 26340726)
21. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
22. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
23. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of cortical lesions in MS: relation with cognitive impairment.
Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
[TBL] [Abstract][Full Text] [Related]
25. Progressive Changes in Cerebral Apparent Diffusion Values in Fabry Disease: A 5-Year Follow-up MRI Study.
Baas KPA; Everard AJ; Körver S; van Dussen L; Coolen BF; Strijkers GJ; Hollak CEM; Nederveen AJ
AJNR Am J Neuroradiol; 2023 Oct; 44(10):1157-1164. PubMed ID: 37770205
[TBL] [Abstract][Full Text] [Related]
26. Effects of amyloid and small vessel disease on white matter network disruption.
Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
[TBL] [Abstract][Full Text] [Related]
27. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
van Norden AG; Fick WF; de Laat KF; van Uden IW; van Oudheusden LJ; Tendolkar I; Zwiers MP; de Leeuw FE
Neurology; 2008 Oct; 71(15):1152-9. PubMed ID: 18838662
[TBL] [Abstract][Full Text] [Related]
28. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
[TBL] [Abstract][Full Text] [Related]
31. Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study.
Dong C; Nabizadeh N; Caunca M; Cheung YK; Rundek T; Elkind MS; DeCarli C; Sacco RL; Stern Y; Wright CB
Neurology; 2015 Aug; 85(5):441-9. PubMed ID: 26156514
[TBL] [Abstract][Full Text] [Related]
32. Effect of Enzyme Replacement Therapy on Basilar Artery Diameter in Male Patients With Fabry Disease.
Miwa K; Yagita Y; Sakaguchi M; Kitagawa K; Sakai N; Mochizuki H
Stroke; 2019 Apr; 50(4):1010-1012. PubMed ID: 30852964
[TBL] [Abstract][Full Text] [Related]
33. Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation.
Lee HJ; Hung SC; Hsu TR; Ko SC; Chui-Mei T; Huang CC; Niu DM; Lin CP
AJNR Am J Neuroradiol; 2016 Jun; 37(6):1044-9. PubMed ID: 26869469
[TBL] [Abstract][Full Text] [Related]
34. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.
O'Brien JT; Lloyd A; McKeith I; Gholkar A; Ferrier N
Am J Psychiatry; 2004 Nov; 161(11):2081-90. PubMed ID: 15514410
[TBL] [Abstract][Full Text] [Related]
35. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.
Debette S; Bombois S; Bruandet A; Delbeuck X; Lepoittevin S; Delmaire C; Leys D; Pasquier F
Stroke; 2007 Nov; 38(11):2924-30. PubMed ID: 17885256
[TBL] [Abstract][Full Text] [Related]
36. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions.
Pantoni L; Fierini F; Poggesi A;
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():10-6. PubMed ID: 26671152
[TBL] [Abstract][Full Text] [Related]
37. Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging.
Fellgiebel A; Albrecht J; Dellani PR; Schermuly I; Stoeter P; Müller MJ
Acta Paediatr; 2007 Apr; 96(455):33-6. PubMed ID: 17391437
[TBL] [Abstract][Full Text] [Related]
38. The cerebral vasculopathy of Fabry disease.
Moore DF; Kaneski CR; Askari H; Schiffmann R
J Neurol Sci; 2007 Jun; 257(1-2):258-63. PubMed ID: 17362993
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
Tokola AM; Salli EK; Åberg LE; Autti TH
Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.
Lobnig BM; Krömeke O; Optenhostert-Porst C; Wolf OT
Diabet Med; 2006 Jan; 23(1):32-9. PubMed ID: 16409563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
